Myc-driven murine prostate cancer shares molecular features with human prostate tumors.
暂无分享,去创建一个
T. Graeber | R. Matusik | C. Sawyers | M. Iruela-Arispe | G. Thomas | John Wongvipat | Charles L Sawyers | George V Thomas | M Luisa Iruela-Arispe | John Wongvipat | Katharine Ellwood-Yen | Thomas G Graeber | Katharine Ellwood-Yen | Robert Matusik | JianFeng Zhang | Jianfeng Zhang
[1] P. Tsichlis,et al. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[2] L. Kretzner,et al. Novel expression patterns of the myc/max/mad transcription factor network in developing murine prostate gland. , 2001, The Journal of urology.
[3] P. Humphrey,et al. A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[4] Chi V. Dang,et al. c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.
[5] Rosalie C Sears,et al. Signaling Networks That Link Cell Proliferation and Cell Fate* , 2002, The Journal of Biological Chemistry.
[6] R. Matusik,et al. Erratum: Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: A model for prostate cancer (Laboratory Iinvestigation (March 1998) 78 (319-333)) , 1998 .
[7] I. Fidler,et al. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] G. Prendergast,et al. Mechanisms of apoptosis by c-Myc , 1999, Oncogene.
[9] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[10] J. Welsh,et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. , 2001, Cancer research.
[11] R. Matusik,et al. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. , 2000, Endocrinology.
[12] T C Gasser,et al. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. , 1999, Cancer research.
[13] E. Bergstralh,et al. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ‐confined prostate cancer , 2002, Genes, chromosomes & cancer.
[14] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[15] D. Felsher,et al. Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations. , 2003, Blood.
[16] G. Evan,et al. Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic Progression , 2002, Cell.
[17] E. Lander,et al. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[18] D. Bostwick,et al. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. , 1999, Journal of the National Cancer Institute.
[19] Stella Pelengaris,et al. c-MYC: more than just a matter of life and death , 2002, Nature Reviews Cancer.
[20] Yun-Fai Chris Lau,et al. Unopposed c‐MYC expression in benign prostatic epithelium causes a cancer phenotype , 2005, The Prostate.
[21] C. Ball,et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.
[22] G. Evan,et al. Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. , 1999, Molecular cell.
[23] E. Prochownik,et al. MYC oncogenes and human neoplastic disease , 1999, Oncogene.
[24] A Ma,et al. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice. , 1991, Oncogene.
[25] S. Dhanasekaran,et al. Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.
[26] A. Iavarone,et al. Id proteins at the cross-road of development and cancer , 2001, Oncogene.
[27] Lene Rask,et al. Astroglial c-Myc Overexpression Predisposes Mice to Primary Malignant Gliomas* , 2003, The Journal of Biological Chemistry.
[28] A. Gartel,et al. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. , 2003, Experimental cell research.
[29] D. Bostwick,et al. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[30] M. Vaarala,et al. The TMPRSS2 gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients: Detection of mutated TMPRSS2 form in a case of aggressive disease , 2001, International journal of cancer.
[31] L. Staudt,et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. , 2003, Cancer cell.
[32] E. Lander,et al. Gene expression correlates of clinical prostate cancer behavior. , 2002, Cancer cell.
[33] O. Kallioniemi,et al. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. , 2000, Cancer research.
[34] R. Cardiff,et al. Nkx 3 . 1 Mutant Mice Recapitulate Early Stages of Prostate Carcinogenesis 1 , 2002 .
[35] Christian A. Rees,et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[36] T. Visakorpi. Molecular genetics of prostate cancer. , 1999, Annales chirurgiae et gynaecologiae.
[37] P. Roy-Burman,et al. Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation , 2001, Mechanisms of Development.
[38] P. Chaurand,et al. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. , 2001, Cancer research.
[39] B. Amati,et al. Myc and the cell cycle. , 1998, Frontiers in bioscience : a journal and virtual library.
[40] R. Hynes,et al. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[41] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[42] Tapio Visakorpi,et al. Molecular genetics of prostate cancer , 2001, Urology.
[43] Peter A. Humphrey,et al. Conditional Loss of Nkx3.1 in Adult Mice Induces Prostatic Intraepithelial Neoplasia , 2002, Molecular and Cellular Biology.
[44] R. Matusik,et al. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[45] D. Hanahan,et al. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. , 1995, Oncogene.
[46] R. Weinberg,et al. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. , 2003, Cancer cell.
[47] M. Rubin,et al. Prostatic neoplasia in transgenic mice with prostate‐directed overexpression of the c‐myc oncoprotein , 2000, The Prostate.
[48] J. Ward,et al. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations. , 1996, Cancer research.
[49] W. Hahn,et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. , 2001, Genes & development.
[50] Andreas Rosenwald,et al. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol , 2001, Genome Biology.
[51] R. T. Curtis,et al. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. , 1997, Genomics.
[52] R. Reiter,et al. Role of prostate stem cell antigen in prostate cancer research , 2002, Current opinion in urology.
[53] R L Vessella,et al. Differential expression of osteonectin/SPARC during human prostate cancer progression. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[54] R. Matusik,et al. Prostate cancer in a transgenic mouse. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[55] A. Berns,et al. Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors , 1989, Cell.
[56] M. Augustus,et al. Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. , 1997, Cancer research.
[57] D. Bostwick,et al. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. , 1997, Cancer research.
[58] Kenneth Chu,et al. Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC , 2002, Science.
[59] C. Perez-stable,et al. Prostate cancer progression, metastasis, and gene expression in transgenic mice. , 1997, Cancer research.
[60] Anton Berns,et al. Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging , 1991, Cell.